Robertson Bruce C 4
4 · RxSight, Inc. · Filed Aug 5, 2021
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Robertson Bruce C
Director
Transactions
- Conversion
Common Stock
2021-08-03+1,385,037→ 1,385,037 total(indirect: See footnote) - Tax Payment
Series H Preferred Stock
2021-08-03−46,875→ 13,628 total(indirect: See footnote)→ Common Stock (46,875 underlying) - Conversion
Series G Preferred Stock
2021-08-03−968,054→ 0 total(indirect: See footnote)→ Common Stock (968,054 underlying) - Exercise/Conversion
Warrant (right to buy)
2021-08-03−60,503→ 0 total(indirect: See footnote)Exercise: $12.40From: 2017-02-24→ Series H Preferred Stock (60,503 underlying) - Exercise/Conversion
Series H Preferred Stock
2021-08-03+60,503→ 60,503 total(indirect: See footnote)→ Common Stock (60,503 underlying) - Conversion
Series H Preferred Stock
2021-08-03−13,628→ 0 total(indirect: See footnote)→ Common Stock (13,628 underlying) - Conversion
Series H Preferred Stock
2021-08-03−403,355→ 0 total(indirect: See footnote)→ Common Stock (403,355 underlying)
Footnotes (4)
- [F1]All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- [F2]Shares and warrant held by H.I.G. BioVentures - Calhoun, LLC. Affiliates of H.I.G. Capital manage all aspects of H.I.G. BioVentures - Calhoun, LLC. Anthony Tamer and Sami Mnaymneh are the managing partners of H.I.G. Capital and as such have the right to direct all activities related thereto. Alex Zisson, Dr. Michael Wasserman, and the Reporting Person are the managing directors of H.I.G. BioVentures - Calhoun, LLC, an affiliate of H.I.G. Capital. The Reporting Person disclaims beneficial ownership of the shares owned by H.I.G. BioVentures - Calhoun, LLC except to the extent of his pecuniary interests therein.
- [F3]All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- [F4]The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock.